Ropes & Gray advised Aptalis, a privately held specialty pharmaceutical company, in its definitive agreement to be acquired by Forest Laboratories, Inc., also a specialty pharmaceutical company. Forest Laboratories has agreed to acquire Aptalis for $2.9 billion in cash from its shareholders, including TPG, a global private investment firm.
The Ropes & Gray team was led by private equity transactions partners William Shields and Michael Roh and included securities & shareholder litigation partner Patrick O’Brien, benefits partner Loretta Richard, tax partner Elaine Murphy, antitrust partner Michael McFalls
, and finance partner Alexander Zeltser.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.